69 results
Page 2 of 4
8-K
EX-99.1
vmoxuih6ysw8h uz
5 May 22
Maravai Lifesciences Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
0kfus 0b7xhb
28 Jan 22
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
8:03am
8-K
EX-10.1
fk7lpf71m7t
20 Jan 22
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
wmq73b2u 71s9
3 Sep 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-2.1
h1ps02t383f x9
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
10-Q
xn333
12 May 21
Quarterly report
4:26pm
10-K
pdu6kamp1yhd5nxx
22 Mar 21
Annual report
4:22pm
8-K
EX-10.9
ipmzb4 i5
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.10
ak17ydcwo
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-1.1
zy4pqugw0 7py0
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.8
03amxu9 lwv7
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
ypkrevo1ndoo46e9y
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1/A
EX-1.1
9d1gmg
9 Nov 20
IPO registration (amended)
2:05pm
S-1/A
EX-10.26
cwdrh5y
9 Nov 20
IPO registration (amended)
2:05pm